Factorial Partners, LLC Eli Lilly & CO Transaction History

Factorial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $701,253 - $825,426	-6,300 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $2.45 Million - $3.06 Million	-28,500 Reduced 81.9%	6,300 $676 Million
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $401,210 - $460,464	-5,300 Reduced 13.22%	34,800 $2.97 Billion
Q1 2018 Apr 23, 2018	BUY	$74.21 - $87.6 $2.98 Million - $3.51 Million	40,100 New	40,100 $3.1 Billion

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Factorial Partners, LLC with notifications on news.